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In Table 2, there are incorrect median values in the Q2 column. Please see the corrected
Table 2 here.
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Table 2. Age and sex-adjusted rates of all-cause mortality and CVD hospitalization by quartile of serum lipids.
Quartile p-value
Q1 Q2 Q3 Q4
Total cholesterol
Median (range), mg/dL 165 (118, 183) 198 (184, 210) 223 (211, 237) 257 (238, 329)
All-cause mortality
Cases (person-years) 341 (43, 630.74) 255 (43, 449.59) 184 (41, 295.09) 139 (41, 238.03)
Rate 60.3 55.5 51.0 49.5 0.027
CHD hospitalization
Cases (person-years) 609 (42, 385.83) 429 (42, 671.84) 306 (40, 716.51) 322 (40, 637.52)
Rate 126.0 97.7 80.6 95.2 <0.001
Stroke hospitalization
Cases (person-years) 504 (42, 683.04) 388 (42, 774.50) 321 (40, 668.79) 297 (40, 714.40)
Rate 98.3 85.0 84.7 93.9 0.361
HDL cholesterol
Median (range), mg/dL 38 (27, 43) 47.7 (44, 51) 56 (52, 61) 69 (62, 98)
All-cause mortality
Cases (person-years) 315 (45, 630.38) 228 (42, 053.36) 191 (42, 115.12) 185 (39, 814.59)
Rate 66.0 52.9 46.0 50.7 <0.001
CHD hospitalization
Cases (person-years) 633 (44, 381.46) 435 (41, 240.43) 337 (41, 467.21) 261 (39, 322.61)
Rate 135.8 103.5 83.7 73.6 <0.001
Stroke hospitalization
Cases (person-years) 487 (44, 749.58) 378 (41, 346.15) 364 (41, 439.38) 281 (39, 305.62)
Rate 110.8 90.4 86.3 71.9 <0.001
Non-HDL cholesterol
Median (range), mg/dL 115 (74, 131) 144 (132, 156) 169 (157, 183) 204 (184, 276)
All-cause mortality
Cases (person-years) 325 (43, 768.99) 253 (42, 218.93) 192 (42, 588.25) 149 (41, 037.27)
Rate 58.0 55.9 50.0 52.7 0.154
CHD hospitalization
Cases (person-years) 558 (42, 614.69) 420 (41, 425.83) 352 (41, 964.77) 336 (40, 406.42)
Rate 117.6 98.0 88.0 96.4 <0.001
Stroke hospitalization
Cases (person-years) 477 (42, 867.75) 383 (41, 571.73) 339 (41, 923.08) 311 (40, 478.17)
Rate 92.1 85.2 85.2 99.8 0.492
LDL cholesterol
Median (range), mg/dL 88 (50, 102) 114 (103, 124) 135.75 (125, 148) 166 (149, 224)
All-cause mortality
Cases (person-years) 314 (41, 816.10) 246 (41, 215.15) 203 (43, 304.18) 156 (43, 278.03)
Rate 60.9 56.0 50.4 49.7 0.015
CHD hospitalization
Cases (person-years) 577 (40, 679.63) 397 (40, 445.12) 342 (42, 666.73) 350 (42, 620.22)
Rate 128.4 95.6 83.1 94.4 <0.001
Stroke hospitalization
Cases (person-years) 460 (40, 965.45) 369 (40, 527.55) 370 (42, 657.15) 311 (42, 690.59)
Rate 95.5 85.2 90.2 91.1 0.606
Non-HDL minus LDL cholesterol
Median (range), mg/dL 16.6 (7.6, 21.0) 26 (22.0, 30.0) 35 (30.6, 40.3) 48.2 (41.0, 93.0)
(Continued)
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Table 2. (Continued)
Quartile p-value
Q1 Q2 Q3 Q4
All-cause mortality
Cases (person-years) 308 (51, 216.52) 239 (42, 451.48) 206 (38, 554.97) 166 (37, 390.47)
Rate 52.6 52.7 53.8 58.5 0.319
CHD hospitalization
Cases (person-years) 449 (50, 328.06) 431 (41, 582.03) 391 (37, 851.46) 395 (36, 650.16)
Rate 85.5 99.8 102.5 118.1 <0.001
Stroke hospitalization
Cases (person-years) 448 (50, 354.07) 420 (41, 656.99) 335 (37, 963.04) 307 (36, 866.61)
Rate 81.4 94.8 87.7 101.0 0.013
Triglycerides
Median (range), mg/dL 74 (43, 91) 108 (92, 124) 147 (126, 176) 232 (179, 628)
All-cause mortality
Cases (person-years) 256 (43, 230.56) 249 (43, 280.85) 222 (42, 904.17) 192 (40, 197.86)
Rate 52.8 53.2 52.0 59.2 0.347
CHD hospitalization
Cases (person-years) 354 (42, 575.48) 400 (42, 462.60) 426 (42, 111.74) 486 (39, 261.89)
Rate 80.9 91.6 99.6 130.7 <0.001
Stroke hospitalization
Cases (person-years) 355 (42, 606.01) 400 (42, 519.69) 410 (42, 135.18) 345 (39, 579.85)
Rate 77.5 88.2 96.0 101.2 <0.001
Ratio total/HDL cholesterol
Median (range), mg/dL 2.96 (2.11, 3.35) 3.70 (3.38, 4.03) 4.42 (4.06, 4.86) 5.58 (4.92, 8.29)
All-cause mortality
Cases (person-years) 261 (42, 536.33) 220 (42, 720.99) 238 (42, 608.40) 200 (41, 747.72)
Rate 53.8 49.1 55.9 58.0 0.276
CHD hospitalization
Cases (person-years) 370 (41, 798.70) 392 (41, 961.01) 435 (41, 806.98) 469 (40, 845.02)
Rate 87.2 91.8 102.1 119.8 <0.001
Stroke hospitalization
Cases (person-years) 386 (41, 761.15) 366 (42, 108.46) 388 (41, 901.78) 370 (41, 069.34)
Rate 81.3 81.3 92.4 107.3 <0.001
Ratio TG/HDL cholesterol
Median (range), mg/dL 1.20 (0.58, 1.57) 2.00 (1.61, 2.44) 3.05 (2.49, 3.84) 5.49 (3.95, 17.88)
All-cause mortality
Cases (person-years) 229 (42, 638.68) 232 (43, 056.65) 241 (42, 876.82) 217 (41, 041.30)
Rate 51.5 49.4 54.6 61.6 0.041
CHD hospitalization
Cases (person-years) 286 (42, 105.98) 395 (42, 282.16) 466 (42, 014.74) 519 (40, 008.84)
Rate 70.3 91.1 107.7 133.2 <0.001
Stroke hospitalization
Cases (person-years) 321 (42, 083.52) 409 (42, 283.75) 398 (42, 119.24) 382 (40, 354.22)
Rate 73.2 90.2 92.0 107.3 <0.001
 CVD: cardiovascular disease; CHD: coronary heart disease; HDL: High density lipoprotein; LDL: low density lipoprotein
Age and sex-adjusted rates: events/10,000 person-years
https://doi.org/10.1371/journal.pone.0205047.t001
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